Aeglea BioTherapeutics, Inc. 4
4 · Aeglea BioTherapeutics, Inc. · Filed May 19, 2016
Insider Transaction Report
Form 4
Rojas-Caro Sandra
Chief Medical Officer
Transactions
- Award
Employee Stock Option
2016-05-17+200,000→ 200,000 totalExercise: $7.28Exp: 2026-05-16→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 1/4th of the shares subject to the option on May 17, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.